Sources Contact Advanced Search Tutorials

An Interest In:

Web News this Week

Search Archive

Some of Our Sources

View All Sources

Help Webnuz

Referal links:

August 1, 2020 09:34 pm

Pre-Clinical Test of Johnson & Johnson Vaccine Shows It Protected Monkeys from Covid-19

"Johnson & Johnson's experimental coronavirus vaccine protected macaque monkeys with a single shot in a pre-clinical study, potentially gaining on other vaccines that are further along in testing but require two doses over time," reports Bloomberg:Five of six primates exposed to the pandemic-causing pathogen were immune after a single injection. The exception showed low levels of the virus, according to a study published in the medical journal Nature... The health-care behemoth kick-started human trials on July 22 in Belgium and in the U.S. earlier this week. Although other vaccine-makers have moved more quickly into development, with AstraZeneca having already administered its experimental vaccine to almost 10,000 people in the U.K., gaining protection with a single dose could prove an advantage in the logistical challenge of rolling out massive vaccination programs worldwide.... The primate data show that the coronavirus vaccine candidate generated a strong antibody response, and provided protection with only a single dose, said Paul Stoffels, the drugmaker's chief scientific officer. J&J aims to embark on the last phase of tests in September, compressing the traditional timeline as it races against others including AstraZeneca, Moderna Inc., Pfizer Inc. and GlaxoSmithKline Plc for a shot to end the pandemic.... The New Brunswick, New Jersey-based drugmaker will test both a one-dose coronavirus shot, and a shot coupled with a booster in its early-stage studies of more than 1,000 adults, which launched this month.

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot